344 related articles for article (PubMed ID: 31016448)
1. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
3. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
[TBL] [Abstract][Full Text] [Related]
5. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
6. Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation.
Curci NE; Triche BL; Abel EJ; Bhutani G; Maciolek KA; Dreyfuss LD; Allen GO; Caoili EM; Davenport MS; Wells SA
Eur Radiol; 2021 Aug; 31(8):5490-5497. PubMed ID: 33492471
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous microwave ablation for local control of metastatic renal cell carcinoma.
Maciolek KA; Abel EJ; Best SL; Emamekhoo H; Averill SL; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Wells SA
Abdom Radiol (NY); 2018 Sep; 43(9):2446-2454. PubMed ID: 29464274
[TBL] [Abstract][Full Text] [Related]
8. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced CT immediately following percutaneous microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes.
Koebe SD; Curci NE; Caoili EM; Triche BL; Dreyfuss LD; Allen GO; Brace CL; Davenport MS; Abel EJ; Wells SA
Abdom Radiol (NY); 2022 Aug; 47(8):2674-2680. PubMed ID: 35278110
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
12. High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation.
Moreland AJ; Ziemlewicz TJ; Best SL; Hinshaw JL; Lubner MG; Alexander ML; Brace CL; Kitchin DR; Hedican SP; Nakada SY; Lee FT; Abel EJ
J Endourol; 2014 Sep; 28(9):1046-52. PubMed ID: 24846329
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous microwave ablation of renal masses in a UK cohort.
John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N
BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: Intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors.
Guo J; Arellano RS
AJR Am J Roentgenol; 2021 Jan; 216(1):117-124. PubMed ID: 32603227
[No Abstract] [Full Text] [Related]
15. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
Zhou W; Arellano RS
J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
[TBL] [Abstract][Full Text] [Related]
16. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
Shakeri S; Afshari Mirak S; Mohammadian Bajgiran A; Pantuck A; Sisk A; Ahuja P; Lu DS; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2308-2315. PubMed ID: 30847565
[TBL] [Abstract][Full Text] [Related]
17. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center.
Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD
Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597
[TBL] [Abstract][Full Text] [Related]
18. CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation.
Wetley KA; Abel EJ; Dreyfuss LD; Huang W; Brace CL; Wells SA
Abdom Radiol (NY); 2020 Sep; 45(9):2810-2824. PubMed ID: 32715335
[TBL] [Abstract][Full Text] [Related]
19. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
[TBL] [Abstract][Full Text] [Related]
20. Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors.
Hao G; Hao Y; Cheng Z; Zhang X; Cao F; Yu X; Han Z; Liu F; Mu M; Dou J; Li X; Dupuy DE; Yu J; Liang P
Int J Hyperthermia; 2018; 35(1):62-70. PubMed ID: 29807450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]